MAKO Surgical Corp. Secures Court-Ordered Permanent Injunction Against Blue Belt Technologies, Inc.

MAKO Surgical Corp. Secures Court-Ordered Permanent Injunction Against Blue
Belt Technologies, Inc.

FORT LAUDERDALE, Fla., April 4, 2013 (GLOBE NEWSWIRE) -- MAKO Surgical Corp.
(Nasdaq:MAKO) today announced that it has obtained an Order Granting Permanent
Injunction enjoining Blue Belt Technologies, Inc. from engaging a former MAKO
employee and requiring the destruction of all proprietary MAKO business
information in Blue Belt's possession.

On January 30, 2013, Blue Belt announced that former MAKO sales manager Jeff
Gellman had been hired as West Area Vice President of Sales. MAKO brought an
action against Blue Belt and Mr. Gellman in the U.S. District Court of the
Southern District of Florida to enforce the non-competition agreement between
MAKO and Mr. Gellman and to prohibit the use or disclosure of MAKO's
proprietary information.

By court order dated April 4, 2013, Mr. Gellman is prohibited from working for
Blue Belt in any capacity until August 2013, and may only work in a limited
capacity thereafter until 2014. Furthermore, both Blue Belt and Mr. Gellman
have been ordered to certify under penalty of perjury that all MAKO
proprietary information in their possession has been permanently purged. The
U.S. District Court retained jurisdiction of the matter to ensure compliance
with its order.

"MAKO is pleased with the sweeping and substantial injunctive relief we
obtained on an expedited basis," said Maurice R. Ferré, M.D., President and
Chief Executive Officer of MAKO. "We will remain vigilant in protecting the
substantial investments made in becoming the leader in the field of
robotically assisted orthopedic surgery."

The Order for Permanent Injunction was entered contemporaneous to a separate
settlement agreement among Blue Belt, Mr. Gellman and MAKO, which provided
MAKO with the described stipulated order, along with additional relief and
future protections.

About MAKO Surgical Corp.

MAKO Surgical Corp. is a medical device company that markets its RIO®
Robotic-Arm Interactive Orthopedic system, with specific applications for
partial knee resurfacing and total hip replacement, and proprietary RESTORIS®
Family of Implants for orthopedic procedures called MAKOplasty®. The RIO is a
surgeon-interactive tactile surgical platform that incorporates a robotic arm
and patient-specific visualization technology, which enables accurate,
consistently reproducible bone resection for accurate insertion and alignment
of RESTORIS implants. The MAKOplasty solution incorporates technologies
enabled by an intellectual property portfolio including more than 300 U.S. and
foreign, owned and licensed, patents and patent applications. Additional
information can be found at www.makosurgical.com.

"MAKOplasty®," "RESTORIS®," "RIO®," as well as the "MAKO" logo, whether
standing alone or in connection with the words "MAKO Surgical Corp." are
trademarks of MAKO Surgical Corp.

CONTACT: MAKO Surgical Corp.
         954-628-1706
         investorrelations@makosurgical.com
 
Press spacebar to pause and continue. Press esc to stop.